ReviewmAbs2016
Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges.
Kathryn Chapman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it
ReviewmAbs2016
Kathryn Chapman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.